Search Result "DAAs treatment"
Recent Advancement of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 18 Issue: 7 Year: 2018 Page: 584-596
Author(s): Debasis Das,Mayank Pandya
Hepatitis C Virus: Efficacy of New DAAs Regimens
Journal: Infectious Disorders - Drug Targets
Volume: 20 Issue: 2 Year: 2020 Page: 143-149
Author(s): Amal Ahmed Mohamed,Naglaa El-Toukhy Ramadan El-Toukhy,Ebada Mohamed Said,Hoda Mohamed Rabie Gabal,Hossameldin AbdelAziz,Wahid Doss,Hadeel El-Hanafi,Hala H. El Deeb,Seham Mahmoud,Mahmoud Elkadeem,Hassan Salama Shalby,Sherief Abd-Elsalam
Predictors for Fibrosis Regression in Chronic HCV Patients after the Treatment with DAAS: Results of a Real-world Cohort Study
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 1 Year: 2020 Page: 104-111
Author(s): Hanan Soliman,Dina Ziada,Marwa Salama,Manal Hamisa,Rehab Badawi,Nehad Hawash,Amal Selim,Sherief Abd-Elsalam
Consensus Treatment Guidelines and Recommendations to Treat Hepatitis-C Infected Populations
Ebook: Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815123432123010010
Pharmaceutical Approaches for Treatment of Hepatitis C virus
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 34 Year: 2020 Page: 4304-4314
Author(s): Alireza Milani,Parya Basimi,Elnaz Agi,Azam Bolhassani
Treatment Recommendations for Harder-to-Cure and Vulnerable Populations
Ebook: Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815123432123010011
Direct-acting Antivirals for Hepatitis C and Implication for Community PharmacyPractice
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 25 Year: 2023 Page: 1967-1970
Author(s):
Impact of Interleukin 28B and ICAM-1 Genetic Polymorphisms on Response to Direct Antiviral Treatment Among HCV Infected Patients
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 8 Year: 2020 Page: 1328-1335
Author(s): Amel G. Elsheredy,Abdulrahman H. Almaeen,Amany A. Ghazy,Ghada F. Helaly,Ibrahim Amer,Haneen A. Ghazy,Tamer Haydara
Aortic Diseases: Abdominal Aortic Aneurysm (AAA) and Dissecting Aortic Aneurysm (DAA)
Ebook: Cardiac Care and COVID-19: Perspectives in Medical Practice
Volume: 1 Year: 2021
Author(s): Ozgur KARCIOGLU
Doi: 10.2174/9781681088204121010010
Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study
Journal: Current Drug Targets
Volume: 18 Issue: 7 Year: 2017 Page: 772-785
Author(s): Laura Gragnani,Alessia Piluso,Teresa Urraro,Alessio Fabbrizzi,Elisa Fognani,Luisa Petraccia,Alessandro Genovesi,Lidia Giubilei,Jessica Ranieri,Cristina Stasi,Monica Monti,Anna Linda Zignego